APP and Alzheimer disease: Estrogen can decrease Aβ production through multiple mechanisms either by increasing the α-secretase activity [48] or reducing BACE1 mRNA expression and activity, therefore, favoring the non-amyloidogenic cleavage of APP and preventing AD pathologies [49].